Biotech on the brink

By Staff Writers
Thursday, 05 February, 2009

A quarter of Australia’s biotechnology companies are in danger of going bust by June this year unless they receive immediate government assistance, AusBiotech CEO Dr Anna Lavelle said.

Nearly half don’t have enough cash to operate beyond 12 months, she said in a statement.

She called on the federal government for assistance through refundable tax credits, competitive matched grants and help in increasing the pool of venture capital.

She listed examples of other countries that have moved to prop up their biotech industries to ride out the credit crisis, including Norway, the UK, Canada, Japan, Germany, China and Taiwan.

“The financial crisis has put at risk a generation of small biotech companies, which are in a precarious position,” she said.

“All of our global trading partners see the sense in supporting biotechnology and are doing this.”

Related News

Novel antibiotic activates 'suicide' mechanism in superbug

Researchers have discovered a new class of antibiotic that selectively targets Neisseria...

Modifications in the placenta linked to psychiatric disorders

Schizophrenia, bipolar disorder and major depression disorder are the neuropsychiatric disorders...

ADHD may be linked with an increased risk of dementia

An adult brain affected by attention deficit hyperactivity disorder (ADHD) presents modifications...


  • All content Copyright © 2025 Westwick-Farrow Pty Ltd